Literature DB >> 6495122

Bone changes after alcohol abuse.

C M Schnitzler, L Solomon.   

Abstract

In this study bone morphometric findings in 19 heavy or moderate drinkers are compared with those in 43 non-drinkers (22 non-osteoporotic patients with osteo-arthritis (OA) and 21 osteoporotic patients with femoral neck fractures (FNFs). Transiliac bone biopsy specimens were examined for assessment of trabecular bone volume and thickness, bone resorption and formation, osteoid seam length and width and the mineralization front by quantitative histomorphometry and microradiography. Trabecular bone volume and thickness were significantly diminished in the drinking group when compared with those in the 22 non-drinking patients with OA (P less than 0,005 and P less than 0,0001 respectively). Bone formation was significantly lower in the drinkers than in the OA group (P less than 0,0005), and bone resorption was significantly greater in the drinkers than in the OA (P less than 0,005) and FNF (P less than 0,01) groups. In heavy drinkers bone formation was significantly lower (P less than 0,05) than in moderate drinkers. The extent of the mineralization front was significantly lower in the drinking group than in the OA (P less than 0,005) and FNF (P less than 0,0005) groups. Osteoid seam length and width did not differ in the three groups. The presence of abnormal liver function test results did not significantly affect any of the parameters. It is concluded that alcohol abuse is associated with: (i) uncoupling of bone resorption and bone formation; (ii) reduced trabecular bone volume and thickness; and (iii) a mild mineralization defect.

Entities:  

Mesh:

Year:  1984        PMID: 6495122

Source DB:  PubMed          Journal:  S Afr Med J


  15 in total

1.  Alcoholism-associated spinal and femoral bone loss in abstinent male alcoholics, as measured by dual X-ray absorptiometry.

Authors:  K S Chon; D J Sartoris; S A Brown; P Clopton
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

2.  Osteoporosis and skeletal fractures in chronic liver disease.

Authors:  T Diamond; D Stiel; M Lunzer; M Wilkinson; J Roche; S Posen
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

3.  Bone mineral density measured by dual-energy X-ray absorptiometry in healthy Finnish women.

Authors:  K Laitinen; M Välimäki; P Keto
Journal:  Calcif Tissue Int       Date:  1991-04       Impact factor: 4.333

4.  Depressive symptoms as a risk factor for osteoporosis and fractures in older Mexican American women.

Authors:  M I Tolea; S A Black; O D Carter-Pokras; M A Kling
Journal:  Osteoporos Int       Date:  2006-10-20       Impact factor: 4.507

Review 5.  Alcohol and bone: review of dose effects and mechanisms.

Authors:  D B Maurel; N Boisseau; C L Benhamou; C Jaffre
Journal:  Osteoporos Int       Date:  2011-09-17       Impact factor: 4.507

6.  The effects of low dose parathyroid hormone on lumbar vertebrae in a rat model for chronic alcohol abuse.

Authors:  K S Howe; U T Iwaniec; R T Turner
Journal:  Osteoporos Int       Date:  2010-06-12       Impact factor: 4.507

7.  Twelve months of voluntary heavy alcohol consumption in male rhesus macaques suppresses intracortical bone remodeling.

Authors:  Gino W Gaddini; Kathleen A Grant; Andrew Woodall; Cara Stull; Gianni F Maddalozzo; Bo Zhang; Russell T Turner; Urszula T Iwaniec
Journal:  Bone       Date:  2014-11-07       Impact factor: 4.398

8.  Bone mineral density and fractures among alcohol-dependent women in treatment and in recovery.

Authors:  M Kathleen Clark; Mary Fran R Sowers; Farideh Dekordi; Sara Nichols
Journal:  Osteoporos Int       Date:  2003-04-30       Impact factor: 4.507

Review 9.  Metabolic bone disease in patients with liver disease.

Authors:  Elizabeth Carey; Vijayan Balan
Journal:  Curr Gastroenterol Rep       Date:  2003-02

10.  Bone histomorphometry, bone mass, and related parameters in alcoholic males.

Authors:  R G Crilly; C Anderson; D Hogan; L Delaquerrière-Richardson
Journal:  Calcif Tissue Int       Date:  1988-11       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.